BindingDB logo
myBDB logout

BDBM237809 US9394282, 5-88

SMILES: NC(=O)c1cn(nc1Nc1ccc(F)cc1)[C@@H]1CN(CC[C@H]1C#N)C(=O)OCC1(CC#N)CC1

InChI Key: InChIKey=BPONMCKOBOWVQW-HNAYVOBHSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 237809   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM237809
PNG
(US9394282, 5-88)
Show SMILES NC(=O)c1cn(nc1Nc1ccc(F)cc1)[C@@H]1CN(CC[C@H]1C#N)C(=O)OCC1(CC#N)CC1 |r|
Show InChI InChI=1S/C23H24FN7O3/c24-16-1-3-17(4-2-16)28-21-18(20(27)32)12-31(29-21)19-13-30(10-5-15(19)11-26)22(33)34-14-23(6-7-23)8-9-25/h1-4,12,15,19H,5-8,10,13-14H2,(H2,27,32)(H,28,29)/t15-,19+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 15n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ...


US Patent US9394282 (2016)


BindingDB Entry DOI: 10.7270/Q2J10233
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM237809
PNG
(US9394282, 5-88)
Show SMILES NC(=O)c1cn(nc1Nc1ccc(F)cc1)[C@@H]1CN(CC[C@H]1C#N)C(=O)OCC1(CC#N)CC1 |r|
Show InChI InChI=1S/C23H24FN7O3/c24-16-1-3-17(4-2-16)28-21-18(20(27)32)12-31(29-21)19-13-30(10-5-15(19)11-26)22(33)34-14-23(6-7-23)8-9-25/h1-4,12,15,19H,5-8,10,13-14H2,(H2,27,32)(H,28,29)/t15-,19+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.700n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ...


US Patent US9394282 (2016)


BindingDB Entry DOI: 10.7270/Q2J10233
More data for this
Ligand-Target Pair